Role of exoproteins in bacterial keratitis: The Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998

Cornea

Volumn 18, Issue 5, 1999, Pages 532-537

  O'Callaghan, Richard J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Keratitis; Protease; Pseudomonas; Staphylococcus; Toxin; Vaccine

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; BACTERIAL TOXIN; CIPROFLOXACIN; PNEUMOCOCCUS VACCINE; PROTEINASE; VACCINE;

BACTERIAL VIRULENCE; CONFERENCE PAPER; HUMAN; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS;

EID: 0032835780     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199909000-00003     Document Type: Conference Paper

References (34)

1. 1 as a corneal glycolipid receptor for Pseudomonas aeruginosa adhesion. Infect Immun 1993;61:5164-73.
2. Panjwani N, Zaidi TS, Gigstad JE, Jungalwala FB, Barza M, Baum J. Binding of Pseudomonas aeruginosa to neutral glycosphingo-lipids to rabbit corneal epithelium. Infect Immun 1990;58:114-8.
3. 1. Infect Immun 1995;63:353-5.
4. Gupta SK, Masinick S, Garrett M, Hazlett LD. Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect Immun 1997;65:2747-53.
5. Zaidi TS, Fleiszig SM, Preston MJ, Goldberg JB, Pier GB. Lipo. polysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci 1996;37:976-86.
6. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun 1994;62:3485-93.
7. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 1997;65:579-86.
8. Finck-Barbancon V, Goranon J, Zhu L, et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997;25:547-57.
9. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 1997;94:12088-93.
10. Pier GB. Pseudomonas aeruginosa: a key problem in cystic fibrosis. ASM News 1998;64:339-47.
11. Engel LS, Callegan MC, Hill JM, Folkens AT, Shimomura Y, O'Callaghan RJ. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol 1996;40:212-9.
12. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res 1993;12:461-7.
13. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun 1994;62:2478-82.
14. O'Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun 1997;65:1571-8.
15. Dajcs JJ, Hume EBH, Moreau JM, et al. The role of Staphylococcus aureus gamma-toxin in corneal virulence. Invest Ophthalmol Vis Sci (in press).
16. Moreau JM, Sloop GD, Engel LS, Hill JM, O'Callaghan RJ. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Curr Eye Res 1997;16:1221-8.
17. Jonas D, Walev I, Liebetrau M, Palmer M, Bhakdi S. Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 1994;62:1304-12.
18. Sloop GD, Moreau JM, Conerly LL, Dajcs JJ, O'Callaghan RJ. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit. Invest Ophthalmol Vis Sci (in press).
19. Hume EBH, Dajcs JJ, Moreau JM, Cannon BM, Hill JM, O'Callaghan RJ. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci 1999; 40:385-91.
20. Fattom AI, Sawar J, Ortiz A, Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 1996;64: 1659-65.
21. Lee JC, Park JS, Shepherd SE, Carey V, Fattom A. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect Immun 1997;65:4146-51.
22. Lowell GH, Colleton C, Frost D, et al. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines. Infect Immun 1996;64:4686-93.
23. Lowell GH, Kaminski RW, Grate S, Hunt R, Charney C, Zimmer S, Colleton C. Intranasal and intramuscular proteosomestaphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect Immun 1996;64:1706-13.
24. Nilsson IM, Patti JM, Bremell T, Hook M, Tarkowski A. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest 1998;101:2640-9.
25. Fattom A, Schneerson R, Szu SS, Vann WF, Shiloach J, Robbins JB. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect Immun 1990;58:2367-74.
26. Fattom A, Schneerson R, Karakawa WW, et al. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus types 5 and 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect Immun 1993;61:1023-32.
27. Balaban N, Novick RP. Autocrine regulation of toxin synthesis by Staphylococcus aureus. Proc Natl Acad Sci USA 1995;92:1619-23.
28. Balaban N, Goldkorn T, Nhan RT, et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 1998;280:438-40.
29. Kernacki KA, Fridman R, Hazlett LD, Lande MA, Berk RS. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naive and immunized mice. Curr Eye Res 1997;16:289-97.
30. Twining SS, Kirschner SE, Mahnke LA, Frank DW. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Curr Eye Res 1993;34: 2699-712.
31. O'Callaghan RJ, Engel LS, Hobden JA, Callegan MC, Green LC, Hill JM. Pseudomonas keratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci 1996;37:535-43.
32. Engel LS, Hobden JA, Moreau JM, Callegan MC, Hill JM, O'Callaghan RJ. Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci 1997;38:1535-42.
33. Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci 1998;39:662-5.
34. Engel LS, Hill JM, Caballero AR, Green LC, O'Callaghan RJ. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem 1998;273:16792-7.